MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Intuitive Surgical Inc

Abierto

SectorSalud

509.04 1.26

Resumen

Variación precio

24h

Actual

Mínimo

503.3

Máximo

513.24

Métricas clave

By Trading Economics

Ingresos

123M

688M

Ventas

374M

2.4B

P/B

Media del Sector

72.947

57.333

BPA

2.21

Margen de beneficio

28.506

Empleados

15,638

EBITDA

116M

810M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+16.53% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-39B

168B

Apertura anterior

507.78

Cierre anterior

509.04

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Intuitive Surgical Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

22 abr 2025, 20:55 UTC

Ganancias

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23 ene 2025, 21:41 UTC

Ganancias

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 ene 2025, 18:37 UTC

Adquisiciones, fusiones, absorciones

Intuitive to Establish Direct Presence in Europe With Acquisition

18 oct 2024, 15:22 UTC

Ganancias
Principales Movimientos del Mercado

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17 oct 2024, 21:33 UTC

Ganancias
Principales Movimientos del Mercado

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17 oct 2024, 20:56 UTC

Ganancias

Intuitive Surgical Posts 3Q Revenue Growth

22 abr 2025, 20:13 UTC

Ganancias

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Net $698.4M >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 abr 2025, 20:05 UTC

Ganancias

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 ene 2025, 21:17 UTC

Ganancias

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 ene 2025, 18:18 UTC

Ganancias

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 ene 2025, 13:11 UTC

Principales Noticias

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 ene 2025, 09:51 UTC

Acciones populares

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 ene 2025, 21:10 UTC

Ganancias

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 ene 2025, 21:09 UTC

Ganancias

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 ene 2025, 21:09 UTC

Ganancias

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 ene 2025, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 ene 2025, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 ene 2025, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 ene 2025, 21:05 UTC

Ganancias

Intuitive Surgical 4Q Net $685.7M >ISRG

23 ene 2025, 21:05 UTC

Ganancias

Intuitive Surgical 4Q EPS $1.88 >ISRG

15 ene 2025, 17:27 UTC

Ganancias

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6 ene 2025, 12:00 UTC

Principales Noticias

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18 oct 2024, 15:59 UTC

Ganancias

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18 oct 2024, 15:38 UTC

Ganancias

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18 oct 2024, 13:28 UTC

Ganancias

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17 oct 2024, 21:18 UTC

Ganancias
Principales Movimientos del Mercado

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

Comparación entre iguales

Cambio de precio

Intuitive Surgical Inc Esperado

Precio Objetivo

By TipRanks

16.53% repunte

Estimación a 12 meses

Media 592.13 USD  16.53%

Máximo 675 USD

Mínimo 470 USD

De acuerdo con 18 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Intuitive Surgical Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

18 ratings

15

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

489.52 / 517.31Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.